{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:16:14Z","timestamp":1788441374925,"version":"build-2803163510"},"reference-count":33,"publisher":"IMR Press","issue":"8","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fund of Scientific Research Innovation of the First Affiliated Hospital of Harbin Medical University","award":["NO.2021B06"],"award-info":[{"award-number":["NO.2021B06"]}]},{"name":"Project of the Health Commission of Heilongjiang Province","award":["20220505010650"],"award-info":[{"award-number":["20220505010650"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background:RING finger protein 126 (RNF126) is an E3 ubiquitin ligase that is overexpressed in various malignancies. However, its role in ovarian cancer remains poorly understood.Methods:Ovarian cancer cell lines, including SKOV3, A2780, and cisplatin-resistant SKOV3\/DDP, were utilized in this study. RNF126 expression was modulated via lentiviral transduction. Cell viability, colony formation, and migration were assessed by cell counting kit-8 (CCK-8), colony formation, and Transwell assays. Protein and mRNA levels were measured by Western blotting and real-time quantitative PCR (qPCR). Protein interaction was evaluated by co-immunoprecipitation and ubiquitination assays. In vivo tumor growth and cisplatin response were examined using a xenograft model.Results:In SKOV3 and A2780 cells, RNF126 overexpression promoted proliferation, colony formation, and migration, while its knockdown produced the opposite effects. Notably, elevated RNF126 expression was observed in the cisplatin-resistant SKOV3\/DDP line. Silencing RNF126 in these cells increased cisplatin sensitivity while concurrently reducing proliferative capacity, clonogenicity, and migratory potential. RNF126 depletion in SKOV3\/DDP cells led to decreased mRNA and protein expression of Notch1 and its downstream targets Myc, Cyclin D3, and Hes1. Meanwhile, Numb mRNA levels remained unchanged, whereas its protein levels increased, indicating post-transcriptional regulation. Furthermore, Numb silencing increased cell viability, clonality, migration, and Notch signaling activation in RNF126 knockdown SKOV3\/DDP cells. In vivo, silencing RNF126 markedly enhanced the sensitivity of cells to cisplatin, suppressed tumor growth, and inhibited Myc, Cyclin D3, Hes1, and Notch1 protein expression. Silencing Numb can reverse the inhibitory effects of RNF126 knockdown. Mechanistic studies showed that RNF126 directly binds to the Notch signaling inhibitor Numb and mediates its ubiquitination and proteasomal degradation, thereby activating the Notch1 signaling pathway and upregulating its downstream genes. In addition, analysis of the TCGA dataset revealed that elevated RNF126 expression is a significant prognostic factor associated with increased mortality risk in ovarian cancer.Conclusions:These findings establish RNF126 as a critical contributor to cisplatin resistance in ovarian cancer via regulation of the Numb\/Notch1 pathway and highlight its potential as a therapeutic target to counteract chemoresistance.<\/jats:p>","DOI":"10.31083\/fbl54223","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:35:31Z","timestamp":1788438931000},"source":"Crossref","is-referenced-by-count":0,"title":["E3 Ubiquitin Ligase RNF126 Promotes Ovarian Cancer Progression and Cisplatin Resistance Through Targeting Numb\/Notch1 Axis"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0590-2401","authenticated-orcid":true,"given":"Tianjiao","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Gynecology, The First Affiliated Hospital of Harbin Medical University, 150001 Harbin, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2954-6320","authenticated-orcid":true,"given":"Han","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The First Affiliated Hospital of Harbin Medical University, 150001 Harbin, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3149-7822","authenticated-orcid":true,"given":"Li","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The First Affiliated Hospital of Harbin Medical University, 150001 Harbin, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5972-6558","authenticated-orcid":true,"given":"Xiaodong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Heilongjiang Provincial Hospital, 150036 Harbin, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7437-6495","authenticated-orcid":true,"given":"Hailiang","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Harbin Medical University, 150081 Harbin, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8735-2297","authenticated-orcid":true,"given":"Xinyan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The First Affiliated Hospital of Harbin Medical University, 150001 Harbin, Heilongjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Konstantinopoulos PA, Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nature Cancer. 2023; 4: 1239\u20131257.","DOI":"10.1038\/s43018-023-00617-9"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Caruso G, Weroha SJ, Cliby W. Ovarian Cancer: A Review. JAMA. 2025; 334: 1278\u20131291.","DOI":"10.1001\/jama.2025.9495"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Jordan KR, Sikora MJ, Slansky JE, Minic A, Richer JK, Moroney MR, et al. The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 2020; 26: 6362\u20136373.","DOI":"10.1158\/1078-0432.CCR-20-1762"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Zhang T, Xu C, Zheng P, Zhang X, Qiu C, Wu F, et al. Glaucocalyxin B Attenuates Ovarian Cancer Cell Growth and Cisplatin Resistance In Vitro via Activating Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2022; 2022: 6324292.","DOI":"10.1155\/2022\/6324292"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Berkel C, Cacan E. Estrogen- and estrogen receptor (ER)-mediated cisplatin chemoresistance in cancer. Life Sciences. 2021; 286: 120029.","DOI":"10.1016\/j.lfs.2021.120029"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Guo C, Song C, Zhang J, Gao Y, Qi Y, Zhao Z, et al. Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine. Genes & Diseases. 2020; 9: 668\u2013681.","DOI":"10.1016\/j.gendis.2020.11.017"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Van Nyen T, Planque M, van Wagensveld L, Duarte JAG, Zaal EA, Talebi A, et al. Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers. Nature Communications. 2022; 13: 4578.","DOI":"10.1038\/s41467-022-32272-6"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Han Y, Wen P, Li J, Kataoka K. Targeted nanomedicine in cisplatin-based cancer therapeutics. Journal of Controlled Release : Official Journal of the Controlled Release Society. 2022; 345: 709\u2013720.","DOI":"10.1016\/j.jconrel.2022.03.049"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Qi G, Ma H, Teng K, Gai P, Gong Y, Chen J, et al. SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT\/mTOR\/Autophagy pathway. Apoptosis : an International Journal on Programmed Cell Death. 2025; 30: 83\u201398.","DOI":"10.1007\/s10495-024-02027-3"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Dou Z, Qiu C, Zhang X, Yao S, Zhao C, Wang Z, et al. HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer. International Journal of Biological Sciences. 2022; 18: 1188\u20131210.","DOI":"10.7150\/ijbs.65589"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Li R, Li H, Lan J, Yang D, Lin X, Xu H, et al. Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 2022; 100: 154084.","DOI":"10.1016\/j.phymed.2022.154084"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Piao Y, Jung SN, Lim MA, Zheng S, Oh C, Jin YL, et al. The role of miR-92b-3p in notch signaling and monitoring of oral squamous cell carcinoma. Oncogene. 2025; 44: 1300\u20131311.","DOI":"10.1038\/s41388-025-03306-2"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Qi Y, Li M, Li S, Zeng D, Xiao Y, Li J, et al. Notch1 promotes resistance to cisplatin by up-regulating Ecto-5'-nucleotidase (CD73) in triple-negative breast cancer cells. Cell Death Discovery. 2023; 9: 204.","DOI":"10.1038\/s41420-023-01487-x"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Zhang R, Liu W, Sun J, Kong Y, Chen C. Roles of RNF126 and BCA2 E3 ubiquitin ligases in DNA damage repair signaling and targeted cancer therapy. Pharmacological Research. 2020; 155: 104748.","DOI":"10.1016\/j.phrs.2020.104748"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Liu W, Sun X, Li F, Jiang Q, An J, Wu Y, et al. An essential role of the E3 ubiquitin ligase RNF126 in ensuring meiosis I completion during spermatogenesis. Journal of Advanced Research. 2025; 73: 231\u2013245.","DOI":"10.1016\/j.jare.2024.08.011"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Liu W, Zheng M, Zhang R, Jiang Q, Du G, Wu Y, et al. RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast Cancer to Radiotherapy. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2023; 10: e2203884.","DOI":"10.1002\/advs.202203884"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Xu H, Ju L, Xiong Y, Yu M, Zhou F, Qian K, et al. E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability. Cell Death & Disease. 2021; 12: 239.","DOI":"10.1038\/s41419-021-03521-1"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Sun Y, Sun H, Qi Y, Pan M, An N, Leng X, et al. Ring finger protein 6 enhances chemo-resistance by transcriptionally activating proliferating cell nuclear antigen expression and attenuating DNA damage in lung adenocarcinoma. Cancer Letters. 2022; 534: 215609.","DOI":"10.1016\/j.canlet.2022.215609"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Li K, Li Y, Zhang Y, Lv J, Zhao T, Dong Y, et al. N6-methyladenosine-modified RNF220 induces cisplatin resistance and immune escape via regulating PDE10A K48-linked ubiquitination in bladder cancer. Biochemical Pharmacology. 2025; 236: 116903.","DOI":"10.1016\/j.bcp.2025.116903"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Vu AD, Mori S, Akamatsu K, Nakayama J, Sakamoto T. Ring-Finger Protein 126 (RNF126) Promotes Anoikis Resistance and Peritoneal Colonization in Ovarian Cancer. International Journal of Molecular Sciences. 2025; 26: 12183.","DOI":"10.3390\/ijms262412183"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Wang H, Yan C, Ye H. RNF126 Promotes Ovarian Cancer Progression by Reprogramming Lipid Metabolism Through Degradation of ACAP2. Biochemical Genetics. 2026; 64: 1624\u20131640.","DOI":"10.1007\/s10528-025-11107-1"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Wang C, Wen A, Qiao J, Liu Y, Guo Y, Wang W. High Expression of RING Finger Protein 126 Predicts Unfavorable Prognosis of Epithelial Ovarian Cancer. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 2020; 26: e921370.","DOI":"10.12659\/MSM.921370"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Bray SJ. Notch signalling: a simple pathway becomes complex. Nature Reviews. Molecular Cell Biology. 2006; 7: 678\u2013689.","DOI":"10.1038\/nrm2009"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Migita K, Matsumoto S, Wakatsuki K, Kunishige T, Nakade H, Miyao S, et al. RNF126 as a Marker of Prognosis and Proliferation of Gastric Cancer. Anticancer Research. 2020; 40: 1367\u20131374.","DOI":"10.21873\/anticanres.14078"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Yu C, Xue B, Li J, Zhang Q. Tumor cell-derived exosome RNF126 affects the immune microenvironment and promotes nasopharyngeal carcinoma progression by regulating PTEN ubiquitination. Apoptosis : an International Journal on Programmed Cell Death. 2022; 27: 590\u2013605.","DOI":"10.1007\/s10495-022-01738-9"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Xie W, Wang J, Tian S, Zhao H, Cao L, Liang Z, et al. RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis. Oncogene. 2024; 43: 1463\u20131475.","DOI":"10.1038\/s41388-024-02949-x"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Sun Z, Liu X, Chen M, Zhang H, Zeng X. Overexpression of RNF126 is associated with poor prognosis and contributes to the progression of lung adenocarcinoma. Biomarkers in Medicine. 2021; 15: 1345\u20131355.","DOI":"10.2217\/bmm-2020-0798"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Guo M, Niu Y, Xie M, Liu X, Li X. Notch signaling, hypoxia, and cancer. Frontiers in Oncology. 2023; 13: 1078768.","DOI":"10.3389\/fonc.2023.1078768"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Biswal S, Panda M, Sahoo RK, Tripathi SK, Biswal BK. Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer. Archives of Oral Biology. 2023; 151: 105697.","DOI":"10.1016\/j.archoralbio.2023.105697"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Kang Y, Ding M, Tian G, Guo H, Wan Y, Yao Z, et al. Overexpression of Numb suppresses tumor cell growth and enhances sensitivity to cisplatin in epithelioid malignant pleural mesothelioma. Oncology Reports. 2013; 30: 313\u2013319.","DOI":"10.3892\/or.2013.2429"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Zhang X, Liu L, Shang M, Hu B, Zhu S, Wang X, et al. YIF1A activates mTORC1 signaling to promote cellular senescence. Cell Death & Disease. 2026.  (online ahead of print)","DOI":"10.1038\/s41419-026-09034-z"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Jiang X, Li J, Zhang J, Zhao Y, He G, Yao X. Ring-finger protein RNF126 promotes prostate cancer progression via regulation of MBNL1. Scientific Reports. 2025; 15: 23847.","DOI":"10.1038\/s41598-025-04629-6"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Hu B, Shang MD, Wang X, Zhang XG, Dong MH, Cao Q, et al. RNF126 suppresses amino acid-mediated mTORC1 signaling pathway by ubiquitinating ILF3 in HEK293T cells. Cellular Signalling. 2025; 136: 112110.","DOI":"10.1016\/j.cellsig.2025.112110"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/8\/10.31083\/FBL54223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:35:32Z","timestamp":1788438932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/8\/10.31083\/FBL54223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02242-2"],"URL":"https:\/\/doi.org\/10.31083\/fbl54223","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"54223"}}